[ Price : $8.95]
Federal Register notice: FDA makes available a guidance on Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions an...[ Price : $8.95]
Federal Register notice: FDA makes available a guidance entitled Regulatory Considerations for Human Cells, Tissues, and Cellular ...[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 11/17/2017.[ Price : $8.95]
FDA releases a guidance on Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Mi...[ Price : $8.95]
Congresswoman Rosa DeLauro (D-CT) reintroduces a bill (HR 4385) that would amend the Food, Drug, and Cosmetic Act to restrict dire...[ Price : $8.95]
Federal Register notice: FDA corrects an 11/3 Federal Register notice entitled Controlled Correspondence Related to Generic Drug D...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on Expedited Programs for Regenerative Medicine Therapies for Seriou...[ Price : $8.95]
FDAs Antimicrobial Drugs Advisory Committee votes 9 to 6 against recommending approval for Bayer HealthCare Pharmaceuticals ciprof...